Atrophy: Clinical Trials

28 trials for Atrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

28 completed. 28 Phase 1, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 128Completed 28
Phase 29Completed 9

Follow Atrophy: new trials by email Literature Review of Atrophy trials Research Report on Atrophy

Trials (filtered) newest first · largest first

All 28 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tolerability of IMM01-STEM in Patients With Muscle Atrophy Related to Knee Osteoarthritis.
IMM01-STEM - Muscle Atrophy
Phase 1 / Phase 2CompletedImmunis, Inc.132022-09-132026-09-09
Electrical Stimulation for Critically Ill Covid-19 Patients
Electrical Stimulation, Electrical Stimulation - Sham - Covid19, Muscle Atrophy
Phase 1CompletedBaylor College of Medicine192020-12-222023-02-16
Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.
PF-06946860 - Cachexia, Non-Small-Cell Lung Cancer
Phase 1CompletedPfizer112020-11-172023-12-14
Effect of a Ghrelin Receptor Agonist on Muscle and Bone
Anamorelin Hydrochloride, Placebo - Sarcopenia, Osteopenia
Phase 1CompletedTufts University322019-12-052024-03-27
Leucine Supplementation in Sarcopenic Older Individuals
Leucine, Placebo - Frail Elderly Syndrome, Sarcopenia
Phase 1CompletedUniversity of Valencia592019-02-012020-04-06
Effects of Chicken Extract and Collagen on Mobility
Collagen hydrolysate and chicken extract - Knee Osteoarthritis, Muscle Loss
Phase 1CompletedShan May Yong1602018-12-012020-07-29
Dose-response Effect of Dietary Nitrate on Muscle Function in Older Individuals
Beet root juice - Aging, Sarcopenia
Phase 1CompletedIndiana University132018-09-012024-07-29
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
Oxytocin nasal spray, Placebo nasal spray - Obesity, Sarcopenic Obesity
Phase 1 / Phase 2CompletedSara Espinoza232017-09-222021-10-22
Nutritional Intervention for Age-related Muscular Function and Strength Losses-Study 2
Placebo, HMB plus Vitamin D, Non-Exercise - Sarcopenia
Phase 1CompletedMetabolic Technologies Inc.2382014-08-012019-02-11
Metformin and Muscle in Insulin-resistant Older Veterans
metformin, placebo - Prediabetes
Phase 1 / Phase 2CompletedVA Office of Research and Development1202014-04-082020-02-11
Omega-3 Fatty Acids to Combat Sarcopenia
Omega-3 fatty acids - Sarcopenia
Phase 1CompletedMayo Clinic242014-03-012015-12-24
Preventive Effect of Proprioceptive Stimulation on Muscle Atrophy
proprioceptive stimulation - Knee Arthritis
Phase 1 / Phase 2CompletedUniversity Hospital, Lille342012-03-012015-04-09
Cedar Honey in Oral Lichen Planus
orally administered cedar honey - Erosive and Atrophic Oral Lichen Planus
Phase 1 / Phase 2CompletedMashhad University of Medical Sciences362011-09-012013-11-01
Study of Inactivity on Metabolism of Elderly Muscles
Step reduction - Sarcopenia
Phase 1CompletedMcMaster University102011-09-012020-02-25
31P MRS Ischaemic Exercise Optimisation and COPD
MRI scan - Atrophy, Muscular
Phase 1CompletedGlaxoSmithKline752010-04-012013-07-01
A Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral SRT2104 Capsules Administered to Healthy Elderly Subjects for 28 Days
Placebo, SRT2104 - Atrophy, Muscular
Phase 1CompletedGlaxoSmithKline242009-10-012017-06-16
A Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Study of ACE-031 in Healthy Postmenopausal Women
ACE-031, Placebo - Muscular Atrophy
Phase 1CompletedAcceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA702009-08-012011-03-23
Nutritional and Contractile Regulation of Muscle Growth
Rapamycin, Amino acid supplementation, Low-intensity resistance exercise - Sarcopenia
Phase 1CompletedThe University of Texas Medical Branch, Galveston1442009-04-012017-05-04
Nutrition and Exercise for Sarcopenia
Amino acids, Exercise - Sarcopenia
Phase 1CompletedThe University of Texas Medical Branch, Galveston1082009-03-012016-12-12
Nutritional Intervention for Age-related Muscular Function and Strength Losses
Placebo, Vitamin D, Beta-hydroxy-Beta-methylbutyrate - Muscle Strength, Sarcopenia
Phase 1CompletedMetabolic Technologies Inc.762008-11-012014-09-17

Showing 20 of 28. Sign in to see all of them.

Narrower conditions

Sarcopenia (16)  ·  Muscular Atrophy (10)  ·  Insulin Resistance (2)  ·  Motor Activity (2)  ·  Anorexia (1)  ·  Bone Diseases, Metabolic (1)  ·  COVID-19 (1)  ·  Cachexia (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Fatigue (1)  ·  Frailty (1)  ·  Hypertrophy (1)  ·  Lichen Planus, Oral (1)

Broader conditions

Pathological Conditions, Anatomical (28)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Neurologic Manifestations (27)  ·  Signs and Symptoms (27)  ·  Nervous System Diseases (26)  ·  Neuromuscular Manifestations (26)  ·  Muscular Atrophy (16)  ·  Nutritional and Metabolic Diseases (4)  ·  Behavior (3)  ·  Metabolic Diseases (3)  ·  Musculoskeletal Diseases (3)  ·  Body Weight (2)  ·  Endocrine System Diseases (2)  ·  Glucose Metabolism Disorders (2)

Interventions

ACVR2B protein, human (2)  ·  Cholecalciferol (2)  ·  Exercise (2)  ·  Leucine (2)  ·  Nitroprusside (2)  ·  Vitamin D (2)  ·  Amino Acids (1)  ·  Amino Acids, Essential (1)  ·  Electric Stimulation (1)  ·  Fatty Acids, Omega-3 (1)  ·  Insulin (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Metformin (1)  ·  Mometasone Furoate (1)  ·  Nortriptyline (1)

Sponsors

The University of Texas Medical Branch, Galveston (3)  ·  Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA (2)  ·  GlaxoSmithKline (2)  ·  Maastricht University Medical Center (2)  ·  Metabolic Technologies Inc. (2)  ·  Baylor College of Medicine (1)  ·  Immunis, Inc. (1)  ·  Indiana University (1)  ·  Mashhad University of Medical Sciences (1)  ·  Mayo Clinic (1)  ·  McMaster University (1)  ·  Nutricia Research (1)  ·  Pfizer (1)  ·  Sara Espinoza (1)  ·  Shan May Yong (1)

Countries

United States (15)  ·  Canada (3)  ·  Netherlands (3)  ·  United Kingdom (2)  ·  France (1)  ·  Germany (1)  ·  Iran (1)  ·  Spain (1)  ·  Taiwan (1)

Top investigators

Luc JC van Loon, PhD (2)  ·  Andrew R Coggan, PhD (1)  ·  Bess Dawson-Hughes, MD (1)  ·  Blake Rasmussen, PhD (1)  ·  Elena Volpi, MD, PhD (1)  ·  Elena Volpi, MD,PhD (1)  ·  Hsin-Nung Shih, MD (1)  ·  Ian R Lanza, PhD (1)  ·  Johannes Gassmueller, M.D. (1)  ·  John A Rathmacher, PhD (1)  ·  John A. Rathmacher, Ph.D. (1)  ·  Majid Sanatkhani, Assistant Professor (1)  ·  Michael O. Thorner, MBBS, DSc, (1)  ·  Omar Cauli, MD, PhD (1)

Results publications

PMID 16030064, PMID 16614412, PMID 16896165, PMID 17351147, PMID 18323467, PMID 18342407, PMID 18713956, PMID 18787087, PMID 20876843, PMID 22338078, PMID 15798081, PMID 16365098, PMID 16464955, PMID 16705054, PMID 16868746, PMID 16873412, PMID 17478528, PMID 17569770, PMID 17885021, PMID 18056791, PMID 18090658, PMID 18236467, PMID 18317375, PMID 18347658, PMID 18403916, PMID 18535123, PMID 18827171, PMID 18845784, PMID 19057193, PMID 19106243, PMID 19150856, PMID 19188252, PMID 19321567, PMID 19588121, PMID 19828686, PMID 20070283, PMID 20150565, PMID 20304764, PMID 20484484, PMID 20519362, PMID 20724580, PMID 20739716, PMID 20844186, PMID 21076294, PMID 21389329, PMID 21430254, PMID 21527663, PMID 21529326, PMID 21606874, PMID 21798089

NIH funding

R01AG018311 (1), R01AG030070 (1), R01AR049877 (1), R21AR074138 (1)